A continuously monitored colorimetric method for detection of Mycobacterium tuberculosis complex in sputum

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 12, 2013, Pages

  Rojas Ponce, Gabriel ^a   Rachow, A ^b,c   Guerra, H ^d   Mapamba, D ^a   Joseph, J ^a   Mlundi, R ^a   Marimoto, S ^a   Ntinginya, N E ^a   Mangu, C ^a   Framhein, A ^a   Butler, A ^a   Kohlenberg, A ^a,b   Ngatemelela, D ^a   Froeschl, G ^b   Maboko, L ^a   Hoelscher, M ^a,b,c   Heinrich, N ^b,c  

^a NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c German Center for Infection Research   (Germany)

^d INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

Author keywords

2,3 diphenyl 5 thienyl (2) tetrazolium STC; Liquid culture; Nitrate reductase assay; Treatment monitoring; TTD

Indexed keywords

4 NITROBENZOIC ACID; ACETYLCYSTEINE; SODIUM HYDROXIDE; TETRAZOLIUM;

ACID FAST BACTERIUM; ARTICLE; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BIOLOGICAL MONITORING; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME ASSAY; HUMAN; INTERMETHOD COMPARISON; LIQUID CULTURE; MYCOBACTERIUM TUBERCULOSIS; NITRATE REDUCTASE ASSAY; NONHUMAN; PNB METHOD; PRIORITY JOURNAL; SAMPLING; SENSITIVITY AND SPECIFICITY; SPUTUM EXAMINATION; STC METHOD; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; COLORIMETRY; DRUG MONITORING; FEASIBILITY STUDIES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SPUTUM; TANZANIA; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 84888123990     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0317     Document Type: Article

References (34)

1. World Health Organization. Global tuberculosis report, 2012. WHO/HTM/TB/2012.6. Geneva, Switzerland: WHO, 2012.
2. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. WHO/CDS/TB/2003.313. Geneva, Switzerland: WHO, 2003.
3. World Health Organization. Laboratory services in tuberculosis control. Part III. Culture. WHO/TB/98.258. Geneva, Switzerland: WHO, 1998.
4. Kent P T, Kubica G P. Public health mycobacteriology: a guide for the level III laboratory. Atlanta, GA, USA: US Department of Public Health and Human Services, Public Health Service, Centers for Disease Control, 1985.
5. Leao S C, Martin A, Mejia G I, et al. Practical handbook for the phenotypic and genotypic identification of mycobacteria. Bruges, Belgium: Vanden Broelle, 2004.
6. Palaci M, Ueki S Y M, Sato D N, da Silva Telles M A, Curcio M, Silva E A M. Evaluation of Mycobacteria Growth Indicator Tube for recovery and drug susceptibility testing of Mycobacterium tuberculosis isolates from respiratory specimens. J Clin Microbiol 1996; 34: 762-764. (Pubitemid 26065818)
7. Caviedes L, Tien-Shun L, Gilman R H, et al., the Tuberculosis Working Group in Peru. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. J Clin Microbiol 2000; 38: 1203-1208. (Pubitemid 30140586)
8. Syre H, Phyu S, Sandven P, Bjorvatn B, Grewal H M S. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol 2003; 41: 5173-5177. (Pubitemid 37429932)
9. Yajko D M, Madej J J, Lancaster M V, et al. Colorimetric method for determining MICs of antimicrobial agents for Mycobacterium tuberculosis. J Clin Microbiol 1995; 33: 2324-2327.
10. Abate G, Mshana R N, Miörner H. Evaluation of a colorimetric assay based on 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1998; 2: 1011-1016. (Pubitemid 29005219)
11. De Logu A, Uda P, Pellerano M L, Pusceddu M C, Saddi B, Schivo M L. Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to rifampin, isoniazid, and streptomycin in liquid medium. Eur J Clin Microbiol Infect Dis 2001; 20: 33-39. (Pubitemid 32200359)
12. Palomino J C, Martin A, Camacho M, Guerra H, Swings J, Portaels F. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2002; 46: 2720-2722. (Pubitemid 34793497)
13. Lee S, Kong D H, Yun S H, et al. Evaluation of a modified a ntimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride. J Microbiol Methods 2006; 66: 548-551. (Pubitemid 44062003)
14. Brent A J, Mugo D, Musyimi R, et al. Performance of the MGIT TBc identification test and meta-analysis of MPT64 assays for identification of the Mycobacterium tuberculosis complex in liquid culture. J Clin Microbiol 2011; 49: 4343-4346.
15. Martin A, Bombeeck D, Fissette K, et al. Evaluation of the BD MGIT TBc identification test (TBc ID), a rapid chromatographic immunoassay for the detection of Mycobacterium tuberculosis complex from liquid culture. J Microbiol Methods 2011; 84: 255-257.
16. Tsukamura M, Tsukamura S. Differentiation of Mycobacterium tuberculosis and Mycobacterium bovis by p-nitrobenzoic acid susceptibility. Tubercle 1964; 45: 64-65.
17. Laszlo A, Siddiqi S H. Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-ol-acetylamino-3-hydroxypropiophenone. J Clin Microbiol 1984; 19: 694-698. (Pubitemid 14142663)
18. Rastogi N, Goh K S, David H L. Selective inhibition of the Mycobacterium tuberculosis complex by p-nitro-α-acetyl-amino-β-hydroxypropio phenone (NAP) and p-nitrobenzoic acid (PNB) used in 7H11 agar medium. Res Microbiol 1989; 140: 419-423. (Pubitemid 19252252)
19. Giampaglia C M S, Martins M C, Inumaru V T G, Butuem I V, Telles M A S. Evaluation of a rapid differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with ρ-nitrobenzoic acid and thiophene-2-carboxylic acid hydrazide. Int J Tuberc Lung Dis 2005; 9: 206-209. (Pubitemid 40278385)
20. Martin A, Waweru P M, Okatch F B, et al. Implementation of the thin-layer agar method for diagnosis of smear-negative pulmonary tuberculosis in a setting with a high prevalence of human immunodeficiency virus infection in Homa Bay, Kenya. J Clin Microbiol 2009; 47: 2632-2634.
21. World Health Organization. Use of liquid TB culture and drug susceptibility testing (DST) in low and medium income settings. Summary report of the Expert Group Meeting on the use of liquid culture media, Geneva, 26 March 2007. Geneva, Switzerland: WHO, 2007. http://www.who.int/tb/laboratory/use-of- liquid-tb-culture-summary-report.pdf Acccessed October 2013.
22. Mueller D H, Mwenge L, Muyoyeta M, et al. Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country. Int J Tuberc Lung Dis 2008; 12: 1196-1202.
23. Palomino J C, Martin A, Portaels F. MODS assay for the diagnosis of TB. N Engl J Med 2007; 356: 188-189.
24. Sanchotene K O, von Groll A, Ramos D, et al. Comparative evaluation of the nitrate reductase assay and the resazurin microtitre assay for drug susceptibility testing of Mycobacterium tuberculosis against first-line anti-tuberculosis drugs. Braz J Microbiol 2008; 39: 16-20. (Pubitemid 351556187)
25. Affolabi D, Odoun M, Sanoussi N, et al. Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. J Clin Microbiol 2008; 46: 3243-3245.
26. Boum Y B II, Orikiriza P O, Rojas G R P, et al. Diagnosis of pulmonary tuberculosis using colorimetric methods in high-burden resource-limited countries. Int J Tuberc Lung Dis 2011; 15: S156.
27. Gupta A, Sen M R, Mohapatra T M, Anupurba S. Evaluation of the performance of nitrate reductase assay for rapid drug susceptibility testing of Mycobacterium tuberculosis in North India. J Health Popul Nutr 2011; 29: 20-25.
28. Lee S M, Kim J, Jeong J, et al. Evaluation of the broth micro-dilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. J Korean Med Sci 2007; 22: 784-790.
29. Toit K, Mitchell S, Balabanova Y, et al. The Colour Test for drug susceptibility testing of Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis 2012; 16: 1113-1118.
30. Epstein M D, Schluger N W, Davidow A L, Bonk S, Rom W N, Hanna B. Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest 1998; 113: 379-386. (Pubitemid 28110014)
31. Diacon A H, Maritz J S, Venter A, et al. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents. Eur J Clin Microbiol Infect Dis 2010; 29: 1561-1565.
32. Mbulo G M K, Kambashi B S, Kinkese J, et al. Comparison of two bacteriophage tests and nucleic acid amplification for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 2004; 8: 1342-1347. (Pubitemid 39611580)
33. Otu J, Antonio M, Cheung Y B, Donkor S, de Jong B C, Corrah T, Adegbola R A. Comparative evaluation of BACTEC MGIT 960 with BACTEC 9000 MB and LJ for isolation of mycobacteria in The Gambia. J Infect Dev Ctries 2008; 2: 200-205.
34. Bonnet M, Gagnidze L, Varaine F, Ramsay A, Githui W, Guerin P J. Evaluation of FASTPlaqueTB™ to diagnose smear-negative tuberculosis in a peripheral clinic in Kenya. Int J Tuberc Lung Dis 2009; 13: 1112-1118. Partnership